Relationship between Volatile Organic Compounds (VOCs) in exhaled breath determined by Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-TOF-MS), clinical characteristics and airway inflammation in COPD

L. Carr (Leicester, United Kingdom), L. Bryant (Leicester, United Kingdom), A. Yousuf (Leicester, United Kingdom), R. Cordell (Leicester, United Kingdom), M. Wilde (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), P. Monks (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom)

Source: International Congress 2018 – Clinical determinants and biomarkers of COPD

Session: Clinical determinants and biomarkers of COPD
Session type: Poster Discussion
Number: 2013

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Carr (Leicester, United Kingdom), L. Bryant (Leicester, United Kingdom), A. Yousuf (Leicester, United Kingdom), R. Cordell (Leicester, United Kingdom), M. Wilde (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), P. Monks (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom). Relationship between Volatile Organic Compounds (VOCs) in exhaled breath determined by Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-TOF-MS), clinical characteristics and airway inflammation in COPD. 2013

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Modelling electronic nose sensor deflections by matching Gas Chromatography-Mass Spectrometry exhaled breath samples Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Distinct volatile markers from Cystic Fibrosis pathogens with Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS) Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018
Exhaled carbon monoxide (CO) as a blood acidity marker in sportsmen Source: International Congress 2014 – Respiratory function at rest and during exercise Year: 2014
Changes in exhaled volatile organic compound profile after breakfast: Implications for protocol development Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014
Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014
Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
MCC-IMS Analyses of Volatile Markers from Exhaled Air for Detection of Bacterial Infection between nasal suction and exhalation through Mouth Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Measurement of volatile organic compounds in exhaled breath of children of the ALL Age Asthma Cohort Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities Year: 2018
Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010
Exhaled Volatile Organic Compounds are Able to Diagnose Systemic Sclerosis Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Breath analysis in relapsing polychondritis using ion mobility spectrometry Source: International Congress 2014 – The assessment of comorbidities Year: 2014
Significant Discrimination of unknown bacterial Infections by Analysis of VOCs in exhaled Air or Headspace from Infected Regions Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020
Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013
Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS) Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012
Comparison of different GC-IMS-devices for measurement of volatile biomarkers (VOC) Source: International Congress 2014 – Airway biomarkers Year: 2014
Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013
Identification of disease specific biomarkers by exhalomics using Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS) in children with cystic fibrosis Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018